
Voters in battleground states are keenly aware of rising healthcare costs and want change, but it’s unclear how this will impact the midterm elections.
The decision follows an investigation officials said uncovered multiple safety concerns that persisted after repeated warnings and corrective action plans.
Temporary Part D subsidies will end this year, although experts disagree on how significant the impact will be.
New work requirements and eligibility checks have states under pressure to roll out system updates on a short timeline.
The bill would extend current price transparency regulations and enshrine them in law, advancing a key Trump administration priority.
By adding diagnoses to a patient’s risk analysis that no doctor had ever indicated, an insurance company can gain additional federal payments.
Proposed payment rules for 2027 will prioritize accountable care organizations, rewarding physicians for maintaining patient wellness.
A handful of large corporations now control medication availability, pricing, and payment for the vast majority of Americans.
A new proposed rule would cut Medicare reimbursement by 40 percent on prescription drugs for providers who already get large discounts.